Sartorius Officially Opens New Manufacturing facility, Germany
Sartorius has announced the opening of its new 25,000m ² facility for the manufacture of laboratory instruments in the industrial zone of Grone in Goettingen. (Source: Drug Development Technology)
Source: Drug Development Technology - October 19, 2017 Category: Pharmaceuticals Source Type: news

Verzenio (abemaciclib) for the Treatment of Metastatic Breast Cancer
Verzenio ™ (abemaciclib) is a cyclin-dependent kinases (CDK) 4 and 6 inhibitor indicated for the treatment of women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), advanced or metastatic breast cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - October 12, 2017 Category: Pharmaceuticals Source Type: news

US ’ George Washington University to conduct Zika virus trial in Brazil
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) in the US is set to conduct the clinical trial of an investigational vaccine for prevention of the Zika infection in Brazil. (Source: Drug Development Technology)
Source: Drug Development Technology - October 10, 2017 Category: Pharmaceuticals Source Type: news

Genmab and Seattle Genetics to perform Phase II trial for cervical cancer
Genmab and Seattle Genetics have collaborated to evaluate tisotumab vedotin in a Phase II clinical trial for the treatment of patients suffering from recurrent and/or metastatic cervical cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - October 10, 2017 Category: Pharmaceuticals Source Type: news

Myeloma UK initiates MUK nine clinical trial for myeloma
Non-profit organisation Myeloma UK has initiated an MUK nine clinical trial that will use genetic techniques to stratify therapy for high-risk myeloma patients in the country. (Source: Drug Development Technology)
Source: Drug Development Technology - October 10, 2017 Category: Pharmaceuticals Source Type: news

Fiasp (insulin aspart) for the Treatment of Type 1 and Type 2 Diabetes
Discovered and developed by Novo Nordisk, Fiasp ® (insulin aspart) is a fast-acting insulin analogue indicated for the treatment of adults with Type 1 and Type 2 diabetes. (Source: Drug Development Technology)
Source: Drug Development Technology - October 10, 2017 Category: Pharmaceuticals Source Type: news

OncoArendi to evaluate OATD-01 in Phase I trial for asthma
Polish biopharmaceutical company OncoArendi Therapeutics is set to conduct a Phase I clinical trial of its lead drug candidate OATD-01 to treat patients suffering from asthma. (Source: Drug Development Technology)
Source: Drug Development Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news

Mundipharma EDO initiates Phase I/II oncology trial of tinostamustine in US
Switzerland-based Mundipharma EDO has initiated a Phase I/II clinical trial of tinostamustine (EDO-S101) to treat patients with advanced solid tumours in the US. (Source: Drug Development Technology)
Source: Drug Development Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news

NanOlogy starts enrolment in Phase II trial of NanoPac for ovarian cancer
US-based pharmaceutical firm NanOlogy has started patient enrolment in a Phase II clinical trial of intraperitoneal (IP) NanoPac (nanoparticle paclitaxel) sterile suspension to treat ovarian cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news

Boehringer and Anthem begin trial to study treatment impact on COPD exacerbations
Boehringer Ingelheim has initiated a pragmatic clinical trial (AIRWISE) in partnership with Anthem and its outcomes research subsidiary HealthCore to investigate the impact of commonly prescribed medicines on exacerbations of chronic obstructive pulm … (Source: Drug Development Technology)
Source: Drug Development Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news

Paratek reports positive data from Phase III trial of omadacycline
Paratek Pharmaceuticals has reported positive safety and efficacy data from a Phase III clinical trial (OPTIC) of its investigational antibiotic, omadacycline, for community-acquired bacterial pneumonia (CABP). (Source: Drug Development Technology)
Source: Drug Development Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news

Sun Pharma ’s Phase III trials of Baclofen GRS fail to meet primary endpoint
India-based Sun Pharma Advanced Research (SPARC) has reported top-line results from two Phase III clinical trials of Baclofen GRS to treat spasticity in patients suffering from multiple sclerosis. (Source: Drug Development Technology)
Source: Drug Development Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news

September ’s top stories: Australia’s Zero Childhood Cancer trial, Eisai & Ono ’s liver cancer trial
Australian cancer centres launched a clinical trial under the Zero Childhood Cancer programme for personalised medicine, and Eisai and Ono Pharmaceutical planned to conduct a Phase Ib combination trial for hepatocellular carcinoma (HCC). Drugdevelopm … (Source: Drug Development Technology)
Source: Drug Development Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news

Janssen ’s Phase III trial of rivaroxaban for embolic stroke stopped early
Janssen Research& Development and its development partner Bayer have stopped the Phase III NAVIGATE ESUS clinical trial of Xarelto (rivaroxaban) assessed as a secondary prevention for stroke and systemic embolism in patients who experienced a recent … (Source: Drug Development Technology)
Source: Drug Development Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news

Inovio reports positive results from Zika vaccine clinical trial
Inovio Pharmaceuticals has reported positive safety and immune response results from a first-in-man, multi-centre Phase I trial (ZIKA-001) of its DNA-based vaccine (GLS-5700) for the treatment of Zika virus. (Source: Drug Development Technology)
Source: Drug Development Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news